Bargain Stocks for Black Friday: Intuitive Surgical

Recs

28

Disney Buys Marvel!

David Gardner called it. He’s up 1,334%! See what David’s recommending that you buy NEXT.

Thanksgiving might be over, but the hunt for deep discounts has just begun! See all of our Foolish picks for Bargain Stocks for Black Friday.

It's a little unreal nominating Intuitive Surgical (Nasdaq: ISRG) as a bargain stock.

This is, after all, the stock that had a trailing P/E of 60 in 2004, when people called it overpriced. Of course, they were wrong, and it nearly tripled within a year.

And then in 2006, when the P/E topped 50, people again called it expensive. And it tripled a year later -- again.

Now it sports a P/E of less than 25.

Twenty-five!

This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, that 25 P/E is pretty darn cheap.

It's the future, stupid
OK. So P/E isn't the best indicator of value. It's backward-looking, after all, and the future might not be so great for the surgical robot maker. Maybe.

Intuitive Surgical is dependent on hospitals for sales of the da Vinci robot, and right now investors don't seem to have much confidence that hospitals will keep spending as they have in the past. Just take a look at how much Intuitive Surgical and some of the other medical device makers have fallen this year.

Company

Year-to-Date Return

Intuitive Surgical

(58.3%)

Kinetic Concepts (NYSE: KCI)

(59.4%)

Boston Scientific (NYSE: BSX)

(47.9%)

Medtronic (NYSE: MDT)

(40.6%)

SonoSite (Nasdaq: SONO)

(46.1%)

Stryker (NYSE: SYK)

(50%)

Zimmer (NYSE: ZMH)

(43.6%)

Source: Morningstar as of Nov. 26, 2008.

So much for health care being a recession-proof industry.

Razors and blades
However, unlike many of the others in the table above, Intuitive Surgical works under the same business model as Gillette did with its razors. It sells the robots (the "razors") for a lower gross margin in order to make more money on the accessories (the "blades") at a higher margin.

The fringe benefit of this model is that there are more than 1,000 robots installed in countries all over the world. That's a lot of machines generating revenue from accessories, quarter after quarter. While the purchase of robots might slow down, people are still going to go in for surgeries, and the hospitals are still going to burn through accessories, even in bad economic times. After investing all that capital in the robot, hospitals aren't going to let it gather dust.

Of course, if hospitals do run into a credit crunch, Intuitive Surgical could always use some of its $400 million in cash and short-term investments to help hospitals finance their purchases (although based on previous management comments, it's more likely to sell to third-party leasing companies). This would help expand the installed base, which helps drive future revenue.

Even if sales do slip, it sounds like Chairman and CEO Lonnie Smith knows that the bottom line, which is driven by margins, is most important. In an interview with the Rule Breakers team, he said, "Fixed and variable costs are important to us. We are big believers in lean manufacturing and lean processes." (You can read the rest of the interview, and get the team’s take, by grabbing a free trial of the newsletter.)

Bottom?
I have no idea whether this is the bottom for Intuitive Surgical. It's entirely possible that the stock could go lower.

What I do know is that if you buy at this price, you're getting a good company with an excellent moat that hasn't actually reported a slowdown yet. Imagine what will happen if revenue growth slows down to just 40% or so. That deflated P/E is going to look mighty cheap at that level.

If you agree that this company will be able to cut through the pessimism that has been bestowed upon it, join me in picking Intuitive Surgical to outperform the market in Motley Fool CAPS. If you think there's no recovery in sight, pick it to underperform.

“The Next Great Investment”… That’s how a top global investor describes India’s potential. On Nov. 28, The Motley Fool’s Tim Hanson returns to India to prove it. Follow along in real time and get his TOP pick first (Hanson returned from China in July with a stock that’s up 169%!). Enter email below.

Find out why The Motley Fool picked Intuitive Surgical and SonoSite for our high-growth Rule Breakers newsletter by grabbing a 30-day trial subscription. You'll get access to all our back issues and the most recent picks. 

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool owns shares of Stryker and Kinetic Concepts. The Fool's disclosure policy was up at 4 a.m. this morning to buy a three-hole punch for its mother.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 28, 2008, at 2:46 PM, wolfhounds wrote:

    Whatever the economy does to ISRG sales in the near term, hospitals worldwide still need to attract the best doctors by offering the best innovations in surgical outcomes and length and stay. In other words, ISRG surgical tools benefit hospitals by attracting higher revenue with lower costs, and benefit the patients as well.

    I missed all those run ups in price exactly because I didn't understand the business. I've since amended my foolishness and bought from $158 to $118. It indeed pays to be a Fool.

  • Report this Comment On December 01, 2008, at 12:51 PM, ttparrish wrote:

    ISRG is the wave of the future. I bought at 118 and sold at 330-350. Now that it is back down I am buying again that this time I intend to buy more shares than I did originally. This market has given us a great opportunity to buy shares in great companies at a significant discount.

  • Report this Comment On January 23, 2009, at 4:42 PM, brit0728 wrote:

    One significant aspect of this stock and its long-term staying power that seems to be overlooked in every article is how costly it is to care for patients in hospital for extended periods postop, particularly for cardiac surgeries. Add to that the not-uncommon complications arising from major surgeries that frequently send patients back into the hospital or extend their stay. Hospitals have terrible reimbursements from all insurance companies, Medicare being among the worst, and the worst writedowns include the daily care costs. If patients can head home from surgeries just days afterward, and run into fewer complications afterwards, everybody wins. The data from IS operations in Europe has been reported for years longer than in the U.S., and it is extremely positive. To my mind, it is more expensive for hospitals to do without robotic surgery; it really is the most significant shift in surgery since laparoscopy. Hospitals are getting on board because they have to stay viable and competitive, and open surgery is just not the way to go anymore. This stock is an unbelievable deal right now - let us know in 10 years how you feel about IS.

Add your comment.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 784438, ~/Articles/ArticleHandler.aspx, 11/24/2009 3:08:14 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Live Chat on India, China, and the Demise of the Dollar

Related Tickers

11/24/2009 2:52 PM
ISRG $279.15 Down -1.65 -0.59%
Intuitive Surgical… CAPS Rating: ****
KCI $34.23 Up +0.34 +1.00%
Kinetic Concepts,… CAPS Rating: *****
BSX $8.52 Up +0.36 +4.41%
Boston Scientific… CAPS Rating: ***
SONO $23.13 Down -0.14 -0.60%
SonoSite, Inc. CAPS Rating: ****
SYK $50.07 Up +0.55 +1.11%
Stryker Corp CAPS Rating: *****
ZMH $58.12 Up +0.16 +0.28%
Zimmer Holdings, I… CAPS Rating: ****
MDT $42.72 Up +2.41 +5.98%
Medtronic, Inc. CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Barriers to entry: Barriers to entry are aspects of a business that inhibit a competitor's efforts to offer equivalent products or services.

Want to learn more or edit this definition?
Click here to read more!